These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 12530042

  • 1. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L, Curigliano G, Colleoni M, Fazio N, Nole F, Martinelli G, Cinieri S, Graffeo R, Peruzzotti G, Goldhirsch A.
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [Abstract] [Full Text] [Related]

  • 2. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, Beuzeboc P, Dorval T, Pouillart P.
    Cancer; 1996 Apr 01; 77(7):1315-23. PubMed ID: 8608509
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
    Niwińska A, Rudnicka H, Murawska M.
    Clin Breast Cancer; 2015 Feb 01; 15(1):66-72. PubMed ID: 25287959
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, Maria B, LaFollette S, Schumann GB, Cole BF, Howell SB.
    Clin Cancer Res; 1999 Nov 01; 5(11):3394-402. PubMed ID: 10589750
    [Abstract] [Full Text] [Related]

  • 5. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    Jaeckle KA, Phuphanich S, Bent MJ, Aiken R, Batchelor T, Campbell T, Fulton D, Gilbert M, Heros D, Rogers L, O'Day SJ, Akerley W, Allen J, Baidas S, Gertler SZ, Greenberg HS, LaFollette S, Lesser G, Mason W, Recht L, Wong E, Chamberlain MC, Cohn A, Glantz MJ, Gutheil JC, Maria B, Moots P, New P, Russell C, Shapiro W, Swinnen L, Howell SB.
    Br J Cancer; 2001 Jan 01; 84(2):157-63. PubMed ID: 11161370
    [Abstract] [Full Text] [Related]

  • 6. Intrathecal chemotherapy for patients with meningeal carcinomatosis.
    Yoshida S, Morii K.
    Surg Neurol; 2005 Jan 01; 63(1):52-5; discussion 55. PubMed ID: 15639526
    [Abstract] [Full Text] [Related]

  • 7. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
    Stemmler HJ, Mengele K, Schmitt M, Harbeck N, Laessig D, Herrmann KA, Schaffer P, Heinemann V.
    Anticancer Drugs; 2008 Sep 01; 19(8):832-6. PubMed ID: 18690096
    [Abstract] [Full Text] [Related]

  • 8. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C, Hoffmann D, Stefani L, Desruet MD, Wang K, Adelstein SJ, Artignan X, Vincent F, Gauchez AS, Zhang H, Fagret D, Vuillez J, Kassis AI, Balosso J.
    Int J Radiat Biol; 2008 Dec 01; 84(12):1123-9. PubMed ID: 19061137
    [Abstract] [Full Text] [Related]

  • 9. Leptomeningeal metastases--treatment results in 98 consecutive patients.
    Pfeffer MR, Wygoda M, Siegal T.
    Isr J Med Sci; 1988 Dec 01; 24(9-10):611-8. PubMed ID: 3144516
    [Abstract] [Full Text] [Related]

  • 10. The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.
    Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, Hart AA, Benraadt J, Vecht ChJ.
    Eur J Cancer; 2004 Dec 01; 40(18):2726-33. PubMed ID: 15571954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of meningeal carcinomatosis: diagnosis and treatment].
    Nakagawa H, Murasawa A, Nakajima S, Nakajima Y, Izumoto S, Kubo S, Hayakawa T.
    No Shinkei Geka; 1992 Jan 01; 20(1):31-7. PubMed ID: 1738424
    [Abstract] [Full Text] [Related]

  • 16. [Case of leptomeningeal carcinomatosis effectively treated with intrathecal chemotherapy using ventriculoperitoneal shunt].
    Miura M, Iijima N, Hayashida K, Kitazawa K, Ishii K, Ohara S.
    Rinsho Shinkeigaku; 2006 Jun 01; 46(6):404-9. PubMed ID: 16986702
    [Abstract] [Full Text] [Related]

  • 17. [Ventriculo-lumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal dissemination of malignant disease].
    Nakagawa H, Fujita T, Kubo S, Izumoto S, Nakajima Y, Tsuruzono K.
    Gan To Kagaku Ryoho; 1991 Jun 01; 18(7):1173-9. PubMed ID: 2053775
    [Abstract] [Full Text] [Related]

  • 18. Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
    Chamberlain MC, Kormanik PA, Barba D.
    J Neurosurg; 1997 Nov 01; 87(5):694-9. PubMed ID: 9347977
    [Abstract] [Full Text] [Related]

  • 19. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL, Buhk JH, Strik H.
    Anticancer Res; 2009 Dec 01; 29(12):5191-5. PubMed ID: 20044635
    [Abstract] [Full Text] [Related]

  • 20. Leptomeningeal metastasis.
    DeAngelis LM, Boutros D.
    Cancer Invest; 2005 Dec 01; 23(2):145-54. PubMed ID: 15813508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.